Manufacturing Roche commits $750m to double Oregon-based US manufacturing capacity Pharmaceutical TechnologyRoche's Oregon fill-finish site will produce both autoinjectors and pre-filled syringes - serving its pipeline and portfolio.Read full story pharminent August 21, 2026 (Last updated: September 1, 2026) Pharmaceutical Technology Roche’s Oregon fill-finish site will produce both autoinjectors and pre-filled syringes – serving its pipeline and portfolio. Read full story Post navigation Previous: Regeneron’s Pasatru Wins Full FDA Approval for Ultra-Rare ‘Stone Man Disease’Next: How cost and perception could reshape the GLP-1 market Related Stories Manufacturing Samsung Biologics inks $262M manufacturing deal with European pharma company pharminent September 11, 2026 Manufacturing Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision pharminent September 9, 2026 Manufacturing US puts $125m into personalised RNA therapy production pharminent September 2, 2026